Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid. - Wikidata - awgldk - TriplyDB

Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid.

Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid.

http://www.wikidata.org/entity/Q34698382

about

Clinical immunologic approaches for the treatment of Alzheimer's disease Immunotherapy as treatment for Alzheimer’s disease Immunization with amyloid-beta attenuates inclusion body myositis-like myopathology and motor impairment in a transgenic mouse model Prototype Alzheimer's disease epitope vaccine induced strong Th2-type anti-Abeta antibody response with Alum to Quil A adjuvant switch Immunotherapy targeting pyroglutamate-3 Aβ: prospects and challenges Sex and Immunogen-Specific Benefits of Immunotherapy Targeting Islet Amyloid Polypeptide in Transgenic and Wild-Type Mice The adjuvanticity of an O. volvulus-derived rOv-ASP-1 protein in mice using sequential vaccinations and in non-human primates A cyclic undecamer peptide mimics a turn in folded Alzheimer amyloid β and elicits antibodies against oligomeric and fibrillar amyloid and plaques Tailoring subunit vaccine immunity with adjuvant combinations and delivery routes using the Middle East respiratory coronavirus (MERS-CoV) receptor-binding domain as an antigen.Abeta-induced meningoencephalitis is IFN-gamma-dependent and is associated with T cell-dependent clearance of Abeta in a mouse model of Alzheimer's disease.White matter changes in dementia: role of impaired drainage of interstitial fluid.Successful adjuvant-free vaccination of BALB/c mice with mutated amyloid beta peptides.Reducing AD-like pathology in 3xTg-AD mouse model by DNA epitope vaccine - a novel immunotherapeutic strategy.Development, characterization, and immunotherapeutic use of peptide mimics of the Thomsen-Friedenreich carbohydrate antigen.The MultiTEP platform-based Alzheimer's disease epitope vaccine activates a broad repertoire of T helper cells in nonhuman primates.DNA prime-protein boost increased the titer, avidity and persistence of anti-Abeta antibodies in wild-type mice.Diminished amyloid-beta burden in Tg2576 mice following a prophylactic oral immunization with a salmonella-based amyloid-beta derivative vaccine.Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal β-catenin pathway function in an Alzheimer's disease model.Alzheimer's disease: is a vaccine possible?Amyloid beta immunization worsens iron deposits in the choroid plexus and cerebral microbleeds.Amyloid-beta immunotherapy for Alzheimer's disease DNA beta-amyloid(1-42) trimer immunization for Alzheimer disease in a wild-type mouse model.Linear and conformation specific antibodies in aged beagles after prolonged vaccination with aggregated Abeta.Analysis of three plasmid systems for use in DNA A beta 42 immunization as therapy for Alzheimer's disease.A new DNA vaccine fused with the C3d-p28 induces a Th2 immune response against amyloid-beta Simvastatin enhances immune responses to Aβ vaccination and attenuates vaccination-induced behavioral alterations Aging and cerebrovascular dysfunction: contribution of hypertension, cerebral amyloid angiopathy, and immunotherapy Low concentrations of anti-Aβ antibodies generated in Tg2576 mice by DNA epitope vaccine fused with 3C3d molecular adjuvant do not affect AD pathology Antigen-specific immunotherapeutic vaccine for experimental autoimmune myasthenia gravis Generation and characterization of the humoral immune response to DNA immunization with a chimeric beta-amyloid-interleukin-4 minigene Co-immunization with DNA and protein mixture: a safe and efficacious immunotherapeutic strategy for Alzheimer's disease in PDAPP mice Co-stimulation with TNF receptor superfamily 4/25 antibodies enhances in-vivo expansion of CD4+CD25+Foxp3+ T cells (Tregs) in a mouse study for active DNA Aβ42 immunotherapy A dual vaccine against influenza & Alzheimer's disease failed to enhance anti-β-amyloid antibody responses in mice with pre-existing virus specific memory.Alzheimer's disease abeta vaccine reduces central nervous system abeta levels in a non-human primate, the Caribbean vervet.Abeta DNA vaccination for Alzheimer's disease: focus on disease prevention.The immunological potency and therapeutic potential of a prototype dual vaccine against influenza and Alzheimer's disease.Evaluation of Borrelia burgdorferi BbHtrA Protease as a Vaccine Candidate for Lyme Borreliosis in Mice.Amyloid-β immunization enhances neurogenesis and cognitive ability in neonatal mice.Combined treatment of Aβ immunization with statin in a mouse model of Alzheimer's disease.Enhancing Th2 immune responses against amyloid protein by a DNA prime-adenovirus boost regimen for Alzheimer's disease

P2860

Q22241380-9B2A6DAA-43E5-4332-9EE2-7310B1D0FB5D Q22241491-0B756B6C-57CA-4EAE-95C2-7C6F511B4EA4 Q24608911-FF7217E5-79EF-4E48-A239-CB187B61E961 Q24676179-70C52741-61E9-4771-A719-1A2C65F02285 Q26745928-8DF868B2-3184-4777-9435-2839F51D777D Q27329865-A91705CA-8CB3-4112-8D81-4E5B1B9B3D03 Q28729899-C2FA8CE7-3EB0-43B6-9EAD-633AD6B6D5E1 Q28740910-968EDCAD-73DF-493A-8411-36C374FC31C9 Q30368736-9D44BD58-916A-4F84-8E86-81DF9814E4BE Q30477260-F6E20BFF-78F7-4EA5-8B74-C5FE2B067150 Q30880445-0C00B288-2101-471D-801D-3904A8D0A029 Q33320228-40F40A9D-E435-41B3-BE4D-F112B9D45E2A Q33332164-95B2D3E6-C76E-4B2F-ACED-0116E017D61B Q33489506-DFFEAB27-D603-42B8-BA35-8AD48D05A2D7 Q33560798-DF11A3D0-BC6A-49C6-8668-2E0654285CCF Q33647708-77D5C2D4-B2F9-4929-B260-7256020A622C Q33742312-0F0C347E-BE76-4B0E-9B58-F1F21D3BFF16 Q33810933-E8BBCA4C-DC19-4318-9C1E-8DB80D392F54 Q33861011-B453E764-8C79-48E4-8632-ED1EC05A01A3 Q33935251-B0F15220-8C30-4FA1-A49D-E4A61B13AB72 Q33954737-510AA24F-4568-4966-B518-9FE343A07BBB Q33957114-05A4E837-568B-42E3-BA6C-52E66FC47265 Q34020477-4FBF41A1-1991-410B-931C-2E4DABF85F87 Q34080692-0C579B5B-694D-49BC-A5F7-0C4F78D67144 Q34094661-E187F936-65F3-4435-8C18-6616DE8E1B83 Q34143153-2AB91A4F-83B9-4A2E-8199-73DC9F7044DB Q34219814-28E110E7-03B3-4D45-AA92-B00A5AFB3231 Q34298878-943743E3-3450-4697-9052-DD738E4CAD5D Q34755933-7EE9BA9A-31DB-4796-BF8C-D990629DEEF5 Q34881830-A4F4340D-33BD-47CA-8088-FF0E0BCCA683 Q34948575-235B8975-A22F-42B4-8862-9E418803828A Q35000579-2673EC5A-637D-49F2-A8C3-8AAF0EAF8A55 Q35040016-C1AE5BA9-AB31-45A3-B178-E0A500DAD496 Q35102897-C737338C-DAC5-41F7-80FE-9C2AB0C50F6C Q35156471-78D260B6-559C-4FA5-846B-6965334028B4 Q35183183-8DD42049-8C57-4651-9457-792AC02AB302 Q35664261-75AC2C21-B71F-4B3C-9305-12227DF5EB3E Q35792042-B0B2E0BF-BA6E-42AC-B40B-79CC7DB47633 Q35818921-8A238CD9-9D68-46F6-A6D0-C8FCBDA3DB4F Q36026890-3E7F1A75-0499-4DFA-B252-B0BEB0DE385E

P2860

Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid.

http://www.wikidata.org/entity/Q34698382

description

2003 nî lūn-bûn

@nan

2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid.

@ast

Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid.

@en

Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid.

@nl

type

label

Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid.

@ast

Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid.

@en

Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid.

@nl

prefLabel

Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid.

@ast

Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid.

@en

Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid.

@nl

P1433

Q34698382-B4206BE0-B23B-439F-9096-1A5674BB8AE9

P1476

Q34698382-6A31CB82-A9EC-44E4-AFFF-53945F4B11A4

P2093

Q34698382-1A627B8A-EC59-4940-9A85-BB4C9695B71A

Q34698382-2301039D-AF2D-4EBB-92CD-09BCE2E0531D

Q34698382-23889115-AD12-412E-8A92-ACC658B1D474

Q34698382-47329B55-35D4-4C4D-86A2-ACED3B5C7287

Q34698382-82B25036-C7D4-4B36-9163-CAB99EA5CAFF

Q34698382-A024BCB9-C684-408F-A0C7-5D7EA4F3E53F

Q34698382-C353DA2E-776F-46AD-8E92-8C649D4CECDE

Q34698382-C4B8554F-BA48-41B1-947D-BDB13B6A0BAF

Q34698382-DBF2E61E-1DB1-4E57-9243-8DAAC7D17545

Q34698382-DEF833E0-A8AF-4452-9368-EE6C89716668

P2860

Q34698382-05090FCF-CBA5-4A99-BDD6-A10D430FD876

Q34698382-0AC1FB14-BBBD-423D-BA84-1F9F354B10E3

Q34698382-13D2E078-81A2-411F-AC58-6A2683F65078

Q34698382-16DDD302-3EEA-4742-9D55-CD4513EE42B4

Q34698382-1CFC8A8C-28CE-484C-880D-CE163FC92BAF

Q34698382-29D94A58-8576-4727-B748-295D617B6E36

Q34698382-31056B30-7DEB-4D7E-A7B6-46BD47D0F25C

Q34698382-321BB47D-2098-4507-AA5E-7DCCF2E0150D

Q34698382-3D6E30B2-15E3-460A-994B-9030F5320B5F

Q34698382-43F3374C-E5E7-4753-8166-5AA94E96D45B

P304

Q34698382-25D4B765-574A-4397-8AB7-92728AEECF3E

P31

Q34698382-94D4BED3-0325-4F46-9807-6C0BD21EE8D0

P356

Q34698382-03A6FE1F-7436-412E-AD26-7BC3730201E6

P433

Q34698382-3439CFF9-2252-4D82-A35F-D02366E7287A

P478

Q34698382-5CE622AF-2237-4303-A19E-345A3B0EDAA0

P577

Q34698382-ED7ABB04-95A1-4BD2-A499-CB09AC023798

P5875

Q34698382-B21A5068-4818-458A-ABDF-5198F4678994

P698

Q34698382-F97F83CC-29F7-4456-B4DC-B69DF35C02E6

P921

Q34698382-9629D3C1-A5BE-4753-8732-30FB7B792FD2

P932

Q34698382-879402FC-C6ED-43D4-A7B6-1715869AB676

P356

P1433

International Immunology

P1476

Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid.

@en

P2093

Anahit Ghochikyan

http://www.w3.org/2001/XMLSchema#string

Carl W Cotman

http://www.w3.org/2001/XMLSchema#string

David H Cribbs

http://www.w3.org/2001/XMLSchema#string

Davit Babikyan

http://www.w3.org/2001/XMLSchema#string

Irina Petrushina

http://www.w3.org/2001/XMLSchema#string

Michael G Agadjanyan

http://www.w3.org/2001/XMLSchema#string

Mike Tran

http://www.w3.org/2001/XMLSchema#string

Nadya Sadzikava

http://www.w3.org/2001/XMLSchema#string

Patrick Kesslak

http://www.w3.org/2001/XMLSchema#string

Thomas Kieber-Emmons

http://www.w3.org/2001/XMLSchema#string

P2860

Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells

Alzheimer's disease: genes, proteins, and therapy

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

Human antibodies reactive with beta-amyloid protein in Alzheimer's disease

beta-Amyloid peptide vaccination results in marked changes in serum and brain Abeta levels in APPswe/PS1DeltaE9 mice, as detected by SELDI-TOF-based ProteinChip technology.

High affinity binding of monoclonal antibodies to the sequential epitope EFRH of beta-amyloid peptide is essential for modulation of fibrillar aggregation.

A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease.

Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer beta-amyloid peptide

Immune hyporesponsiveness to amyloid beta-peptide in amyloid precursor protein transgenic mice: implications for the pathogenesis and treatment of Alzheimer's disease

Transgenic mouse models of Alzheimer's disease.

P304

505-514

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/INTIMM/DXG049

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2003-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7794803

http://www.w3.org/2001/XMLSchema#string

P698

12663680

http://www.w3.org/2001/XMLSchema#string

P921

P932

1483061

http://www.w3.org/2001/XMLSchema#string